U.S. Tech Hardware Stock News

NasdaqGM:MDB
NasdaqGM:MDBIT

MongoDB (MDB) Valuation Check After Fiscal 2025 Results Guidance Reset And Voyage AI Acquisition

MongoDB (MDB) has become a talking point again after reporting fiscal 2025 revenue of US$2.01b, driven mainly by Atlas, while issuing a 2026 outlook below analyst expectations and highlighting new AI plans through its Voyage AI acquisition. See our latest analysis for MongoDB. The share price has pulled back sharply in recent months, with a 30 day share price return of 23.76% and a 90 day share price return of 37.27%, even though the 1 year total shareholder return is 42.72%. Recent swings...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

Is It Time To Reassess Texas Capital Bancshares (TCBI) After Its Recent Share Price Pullback

If you are wondering whether Texas Capital Bancshares at around US$91.83 is offering good value today, you will want to see how its current price compares with a few different valuation tools. The stock has been fairly steady over the year to date with a 0.1% return, following a recent 12.0% pullback over 30 days and a 21.5% gain over the past year. These moves may have reshaped how the market is pricing its risks and opportunities. Recent coverage has focused on Texas Capital Bancshares as...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

How Brinsupri’s US$28 Million Launch And Analyst Interest At Insmed (INSM) Has Changed Its Investment Story

In recent weeks, Insmed has attracted fresh attention as Jefferies initiated coverage with a positive view, while Artisan Partners highlighted the company’s role in its Artisan Small Cap Fund before exiting the position for market cap reasons. This burst of interest has centered on Insmed’s newly launched Brinsupri™ (brensocatib) for non-cystic fibrosis bronchiectasis, which generated US$28 million in initial sales and underscored the appeal of its broader rare-disease pipeline among...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

How LKQ’s (LKQ) Earnings Miss and Board Change Will Impact Cost-Focused Investors

LKQ Corporation disclosed that director Patrick Berard has declined to stand for re-election and will remain on the board until the company’s 2026 annual stockholders’ meeting expected in May 2026. Coupled with recent quarterly results that beat revenue expectations but missed earnings and guidance, this board change adds another layer to LKQ’s ongoing operational and governance reshaping. Next, we’ll examine how LKQ’s earnings miss and evolving board composition may influence the company’s...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

Is It Too Late To Consider AeroVironment (AVAV) After Its Strong Multi‑Year Share Price Run?

Wondering if AeroVironment’s US$211.35 share price still offers value after a strong run, or if you might be looking at a stock that has already priced in much of its story? The stock has slipped around 0.3% over the last week and 19.6% over the past month, yet it still shows a 17.5% decline year to date and a 68.9% gain over the past year, with a 136.3% result over three years and 84.3% over five years. Recent coverage has focused on AeroVironment’s role within the aerospace and defense...
NYSE:KR
NYSE:KRConsumer Retailing

Has Kroger (KR) Run Too Far After Strong Multi‑Year Share Price Gains?

If you are wondering whether Kroger's current share price still offers value after a strong run, this breakdown will help you see how the market is pricing the business today. Kroger's stock closed at US$73.76, with returns of 5.9% over the last 30 days, 17.2% year to date, 16.3% over 1 year, 62.4% over 3 years, and 124.8% over 5 years. These figures may shape how you think about the balance between risk and reward now. Recent coverage has focused on Kroger's position as a major US grocer...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Ulta Beauty Speeds K-Beauty And Wellness Push To Refresh Growth Story

Ulta Beauty (NasdaqGS:ULTA) is expanding its K-Beauty World marketplace with 17 Korean beauty brands, aiming to bring viral products to U.S. shoppers in as little as nine weeks. Dr. Melaxin, a K-Beauty brand that gained traction online, is moving from the marketplace to a nationwide in-store rollout across 1,500 Ulta locations. These moves are tied to Ulta’s broader push into wellness and faster product launch cycles. They extend beyond previously discussed earnings and guidance...
NYSE:SPGI
NYSE:SPGICapital Markets

S&P Global Adds Enertel AI As Power Forecasting And Valuation Questions Grow

S&P Global (NYSE:SPGI) has acquired Enertel AI Corporation to add real time, AI powered power price forecasting for North American electricity markets. The deal aims to provide physical power traders, utilities, and asset operators with AI driven tools for intraday and short term power market decisions. The acquisition expands S&P Global's energy analytics offering by embedding machine learning models directly into existing power market workflows. S&P Global, trading at $426.14 under ticker...
NasdaqGS:POWL
NasdaqGS:POWLElectrical

A Look At Powell Industries (POWL) Valuation After Strong Multi Year Shareholder Returns

With no single headline event driving attention to Powell Industries (POWL), recent trading performance is front and center, with the stock showing strong past 3 months and 1 year total returns, alongside positive annual revenue and net income growth. See our latest analysis for Powell Industries. The recent 4.61% 1 day and 2.31% 7 day share price returns come after a 6.45% 30 day pullback, yet momentum over the past quarter and year still looks strong, with very large multi year total...
NYSE:PRU
NYSE:PRUInsurance

A Look At Prudential Financial's Valuation As Andrew Sullivan Assumes Chairman Role

Leadership changes put Prudential Financial (PRU) in focus Prudential Financial (PRU) is back on investors’ radars after the board expanded Chief Executive Officer Andrew Sullivan’s responsibilities by appointing him Chairman and marking the retirement transition of long serving leader Charles Lowrey. See our latest analysis for Prudential Financial. At a share price of US$92.51, Prudential’s 30 day share price return of 10.42% and year to date share price return of 18.76% point to pressure...
OTCPK:LICT
OTCPK:LICTTelecom

LICT (OTCPK:LICT) Margin Compression To 8.6% Challenges High Quality Earnings Narrative

LICT (OTCPK:LICT) has posted its FY 2025 results with fourth quarter revenue of US$36.3 million and basic EPS of US$77.49, while trailing twelve month figures show revenue of US$141.4 million and basic EPS of US$771.44. Over the past six reported quarters, revenue has moved from US$33.4 million in Q4 2024 to US$36.3 million in Q4 2025 as quarterly EPS shifted from US$425.67 to US$77.49. This sets the backdrop for a trailing net profit margin of 8.6% versus 15.4% a year earlier. For investors,...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Is Vertex Pharmaceuticals (VRTX) Offering Value After Recent Share Price Pullback?

Wondering if Vertex Pharmaceuticals at around US$458 a share is offering fair value, a bargain, or something in between? This breakdown is built to help you size that up quickly. The stock is up 1.3% year to date, with shorter term moves of a 4.2% decline over the last week and a 4.0% decline over the last month. These moves can change how the market is thinking about both risk and opportunity. Recent headlines have focused on Vertex's position within big pharma and biotech, touching on its...
OTCPK:HBIA
OTCPK:HBIABanks

Hills Bancorporation (OTCPK:HBIA) Margin Expansion Reinforces Bullish Profitability Narratives

Hills Bancorporation (HBIA) has wrapped up FY 2025 with fourth quarter total revenue of US$41.5 million and basic EPS of US$1.65, capping a trailing twelve month run that totals US$161.1 million in revenue and US$6.82 in EPS. Over recent quarters the company has seen revenue move from US$35.0 million and EPS of US$1.23 in Q4 2024 to US$44.4 million and EPS of US$2.09 in Q2 2025, before landing at Q4 2025 levels, giving investors a clear view of both top line scale and per share profitability...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Is Hamilton Lane (HLNE) Attractive After Recent Share Price Slide And Mixed Valuation Signals

If you are wondering whether Hamilton Lane's current share price reflects its underlying value, the recent trading history gives you a lot to think about. The stock last closed at US$101.00, with returns of 7.2% over 7 days, a 15.8% decline over 30 days, a 26.1% decline year to date, a 31.1% decline over 1 year, but gains of 49.1% over 3 years and 31.9% over 5 years. Recent coverage has focused on how these mixed returns may influence investor sentiment toward Hamilton Lane and similar...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Align Technology (ALGN) Is Up 5.6% After Elliott Builds Activist Stake Is The Bull Case Changed?

In March 2026, Bloomberg reported that activist investor Elliott Investment Management had built a significant stake in Align Technology and intended to engage with the company on ways to increase shareholder value. This move places a high-profile activist among Align's largest investors, potentially influencing decisions on capital allocation, cost structure, and longer-term business priorities. We’ll now examine how Elliott’s activist involvement could influence Align’s existing investment...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

What Plains All American Pipeline (PAA)'s NGL Exit and Cactus III Integration Means For Shareholders

Plains All American Pipeline recently amended key credit facilities in Canada and advanced its shift toward a pure crude oil operation by selling its NGL business and integrating the newly acquired Cactus III pipeline. This restructuring of both assets and credit arrangements underscores how the company is reshaping its capital structure and operational footprint to prioritize more predictable, crude-focused cash flows and efficiency gains. Next, we’ll examine how Plains All American’s NGL...
NYSE:IHS
NYSE:IHSTelecom

Did IHS Holding's (IHS) Q4 Net Loss Amid Rising Sales Just Recast Its Investment Narrative?

IHS Holding Limited recently reported fourth-quarter 2025 results, with sales edging up to US$397.8 million while swinging from a prior-year net income of US$246.5 million to a net loss of US$75.8 million. The shift to a basic loss per share of US$0.23, despite higher continuing-operations earnings per share, points to pressures outside the core tower business. We’ll now examine how this move to a quarterly net loss, alongside only modest revenue growth, affects IHS Holding’s existing...
NYSE:TDC
NYSE:TDCSoftware

Teradata (TDC) Valuation Check After New AI Infrastructure Partnership And Enterprise Vector Store Upgrades

Teradata (TDC) shares are drawing attention after the company announced a new partnership with Unstructured along with fresh agentic and multimodal features for its Enterprise Vector Store, sharpening its focus on enterprise AI infrastructure. See our latest analysis for Teradata. Despite the AI-focused announcements, Teradata’s recent share price performance has been mixed, with a 1-day share price return of 1.24% and a 7-day return of 0.97% contrasting with a 30-day share price decline of...
NYSE:ZIM
NYSE:ZIMShipping

How ZIM’s 2025 Dividend Payout And Tax Clarity Has Changed Its Investment Story (ZIM)

ZIM Integrated Shipping Services reported fourth-quarter 2025 net income of US$38.1 million and full-year net income of US$479.2 million, both sharply lower than the prior year, while also disclosing modest declines in carried volumes. The company nevertheless returned US$240 million, or US$1.99 per share, in dividends for 2025, and clarified Israeli withholding tax procedures that could allow some shareholders to receive this payout at a reduced tax rate. We’ll now consider how ZIM’s...
NYSE:LNC
NYSE:LNCInsurance

Ethics Recognition And Undervalued P/E Shape Lincoln Financial Investment Case

Lincoln Financial Group (NYSE:LNC) has been recognized as one of the World's Most Ethical Companies by Ethisphere for the fifth consecutive year. The 2026 recognition highlights the company's continued focus on ethics, compliance, and responsible business practices. The accolade reinforces Lincoln Financial's positioning around corporate governance, brand reputation, and stakeholder trust. For investors following insurers and retirement providers, ethics and governance can be just as...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

A Look At F5 (FFIV) Valuation After New NVIDIA And Skyfire AI Infrastructure Updates

F5 (FFIV) shares are back in focus after a series of AI centric announcements, including a Skyfire partnership for verified agent traffic and expanded NVIDIA powered inference capabilities within its application delivery and security platform. See our latest analysis for F5. Those AI focused product releases and partnerships with NVIDIA and Skyfire have coincided with building momentum, with a 30 day share price return of 7.29% and a year to date share price return of 13.12%, while the 3 year...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Is It Time To Reassess Constellium (CSTM) After Its 102% One-Year Share Price Surge

Investors may be wondering whether Constellium’s current share price reflects its real worth, or if the market is overlooking something important in the story. Over the past year the stock has returned 101.7%, with a year-to-date return of 20.0%, a 30-day return of 1.3% and a 7-day return showing a 3.5% decline, which may have investors reassessing both upside potential and risk. Recent coverage around Constellium has focused on its role in the materials sector and how sentiment toward the...
NYSE:O
NYSE:ORetail REITs

Realty Income Apollo Venture Reshapes Capital Mix And Valuation Story

Realty Income (NYSE:O) has entered a $1 billion joint venture with Apollo for a 49% interest in a portfolio of about 500 single-tenant retail properties. The transaction advances Realty Income's private capital initiative by adding a new funding partner while the company keeps long-term management and future call rights. The deal is intended to diversify capital sources beyond traditional markets and support future investment activity in the net lease space. For investors watching NYSE:O,...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Medicare Coverage for PanTracer LBx Liquid Biopsy Could Be A Game Changer For NeoGenomics (NEO)

NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test for advanced solid tumors has secured Medicare coverage under the MolDX LCD for plasma-based genomic profiling, enabling covered access to a blood-based panel that analyzes more than 500 genes from a CLIA-certified lab with a seven-day turnaround. This coverage decision not only broadens access to noninvasive genomic testing for Medicare beneficiaries but also highlights the growing clinical role of liquid biopsy...